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*O*ver the years, hand-written prescription has been a preferred communication method for physicians in decisions relating to medication therapy and for pharmacists to distribute medications. It is also considered as a valuable resource for the patients on how to use the medicine to achieve the maximum benefit.\[[@ref1]\]

In the last decade, electronic prescription is always considered as an interested subject among other electronic health solutions to process the health-related data.\[[@ref1][@ref2][@ref3][@ref4]\]

In fact, electronic prescription is a broad term that means using the computer devices to enter, modify, review, and generate or transmit medicine prescriptions that prepare two-way transmissions between the point of care and the dispenser. This form of technology would safely transmit prescription or prescription-related information between stakeholders (prescribers, dispensers, pharmacies, health plans, and health insurers) either directly or through an intermediary (including an electronic prescription network) using electronic media.\[[@ref2][@ref3][@ref4][@ref5][@ref6][@ref7][@ref8]\]

The electronic prescription system connects to information systems in health-care organizations such as hospitals, health-care centers, and pharmacies. The implementation of it can overcome many problems of paper prescribing process and will bring benefits, including cost savings, reducing prescription errors, increasing prescription legibility, improving medication therapy outcomes, reducing redundant paperwork, electronically accessing to updated pharmacopeia information, and patient medication history.\[[@ref9][@ref10][@ref11][@ref12][@ref13][@ref14][@ref15][@ref16][@ref17]\]

Electronic prescription has been discussed in many experts\' reports and public national plans, and it is tested, implemented, or are implementing in several European and the United States countries.\[[@ref18][@ref19][@ref20][@ref21]\] Electronic prescription systems have been designed and implemented according to the domestic needs of each country, and different standards are also established to make it better every year.\[[@ref22][@ref23][@ref24][@ref25]\] Implementation of electronic prescription systems is an irreversible intervention in the prescribing process. This system is a representative of the multidisciplinary sociotechnical information systems that has a wide scope, different specialties, numerous complexities, various actors and subsystems, distinct implementation process, and specific technical solutions in each country. Medicine is the most important part of therapy supported by the governments of many nations. In addition, the process of medication prescription and consumption is one of the important pillars of the health system in each country.\[[@ref7][@ref26][@ref27]\]

Today, the necessity of using electronic prescription systems can be felt more than ever due to their many benefits. Therefore, study on this system as a systematic or comprehensive review has been done.\[[@ref12][@ref28][@ref29][@ref30][@ref31]\] However, since many countries, especially developing countries, still use manual traditional prescription systems, using the experiences of leading countries is very necessary and useful to develop and design the electronic prescription system in the other countries. Taking into account the above considerations, the aim of the present study is to identify and compare national electronic prescription system in the selected countries.
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This review study was done in the period of 2013--2015. Countries with the electronic prescription system were selected. The selection process of the countries was as follows:

Since electronic prescription has been fully implemented only in a few European countries and the United States, it has been adopted as a part of the national electronic-health strategy in the European Union (EU) countries.\[[@ref32][@ref33]\] EU countries (27 countries) and the United States were selected in the first stageAt this stage, the definition of electronic prescription was applied for countries selection. The range of the definitions was broad from creating electronic prescription to electronic transmission and processing. There was no generally agreed and same definition for electronic prescription.\[[@ref34][@ref35]\] Therefore, three key features of the electronic prescription definitions were used for selection of the countries included: creating electronic prescription, electronically sending electronic prescription to the pharmacy, and two-way transmissions between the point of care and the pharmacy. As a result of this step, eight countries (Denmark, Finland, Germany, New Zealand, the Netherlands, Sweden, England, and the United States) were selected due to the possibility of creating electronic prescriptions\[[@ref23][@ref26][@ref36][@ref37][@ref38][@ref39][@ref40]\]In the final stage, the national prescription system in each country was studied in terms of the capability of electronically transmitting prescriptions (ETPs) to the pharmacies and two-way electronic communication between the prescriber and dispenser. In the end, five countries (Denmark, Finland, Sweden, England, and the United States) were selected which were approved based on the other criteria of the existing studies review in this field.

A form of data collection was designed and developed based on the main components of the prescription system model\[[@ref4][@ref6][@ref8][@ref39]\] to collect data from the selected countries, including as follows:

Legal infrastructure of the electronic prescription systems (adoption of the electronic prescription law, adoption of the electronic prescription transmission law, issuing the electronic prescriptions for controlled medicines, issuing a paper prescription if needed, legality of the prescription electronic signature, patient satisfaction to participate in this service, and patient satisfaction to access stakeholders to needed information)Accepting prescriptions from other countries (dispensing fax, paper and electronic prescriptions, approving dispensation laws, constraints)Electronic prescription system architecture (architecture type, national electronic prescription database, patient demographic database, national medicine database, national electronic health record, personal electronic medicine profile, the Internet, dedicated national health network, national electronic prescription network, national electronic health portal)Responsibility of the electronic prescription system (coordination and leading electronic health, financing, creating and maintaining national electronic prescription database, establishing a dedicated health network, implementing a national health portal)Electronic prescription system identifiers (national patient identifier, medicine identifier, physician identifier, technology of confirming the identification of the prescriber and dispenser, prescription unique identifier (PUID), pharmacy identifier)The process of electronic prescription system (electronic prescription, requesting the needed information, capabilities of decision support, providing the required information, choosing the pharmacy by the patient, electronic dispensation of medication, ETPs to the pharmacies, electronically retrieving the prescription at the pharmacies, electronic dispensing, storing electronic prescription in national prescription database, informing the prescribing physician of the dispensation (fill) status, transferring the dispensed prescription into the national electronic prescription database, electronic submission of reimbursement claims, electronically repeating or refilling the prescription).

Data were extracted by combination search of the keywords pertaining to electronic prescription with AND/OR operators in the search engines and databases of Google, Yahoo, Google Scholar, PubMed, ProQuest, and Iranian National Library of Medicine without time limitation: "Eprescri\*" OR "e-prescri\*" OR "electronic prescri\*" OR "e-Rx" OR "electronically transmitting prescription (ETP)" OR "Medical order entry systems" OR "eDispensing" OR "electronic dispensing" OR "two-way electronic order system" OR "Computerized Physician Order Entry (CPOE)" OR "Prescription routing services" AND the name of each five selected countries. All retrieved papers, research projects, theses, directories, and progress reports in English were scrutinized. In addition, authorized organizations\' web sites, national health-care networks, and national central databases concerned with electronic prescription system of each country were also visited and their available documentations were studied. To clarify the ambiguity in the electronic prescription system of the studied countries, an E-mail was sent to the related organizations (MedCom and sundhed in Denmark, Kela and KanTa in Finland, Apotekens Service and lakemedeletjanster in Sweden, NHS CFH in England, and Surescripts in the United States). Data collection form was completed according to the retrieved information sources.

Then, the similarities and differences of the electronic prescription system models in the selected countries were shown in comparative tables.
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The results of the comparative review of the electronic prescription in the studied countries are listed in Tables [1](#T1){ref-type="table"}--[4](#T4){ref-type="table"}. In [Table 1](#T1){ref-type="table"}, the legal infrastructures of the electronic prescription system have been investigated and compared. Based on the results, prescriber\'s electronic signature was legal in these countries and patient\'s satisfaction was necessary for stakeholders to access to the required information.
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Comparison of the legal infrastructure of the electronic prescription system in the selected countries
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Comparison of the electronic prescription system architecture in the selected countries
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Comparison of the electronic prescription system identifiers in the selected countries
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Comparison of the electronic prescription system processes in the selected countries
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The overall comparison of the selected countries in terms of accepting prescriptions from other countries showed that none of the electronic prescription system of these countries accept electronic prescription from other countries (nonnational), although dispensation acts for these prescriptions have been approved in Sweden, Finland, and Denmark. However, a number of local pilot projects to accept the nonnational electronic prescriptions are in progress in Denmark.\[[@ref41][@ref42]\] In addition, dispensing fax or paper prescriptions relevant to northern Europe in four European studied countries is possible, but there are constraints for these prescriptions such as type of the medicines, type of the prescriptions (paper, fax and...), accuracy, and validity of the prescriptions. Rejection of the nonnational electronic prescription in the selected countries is due to the lack of standardization and legislation in this area, legal prohibition, verification and authentication problems, concerns about privacy and security of electronic prescriptions, and poor interaction and communication between health systems.\[[@ref22][@ref23][@ref25][@ref43][@ref44][@ref45]\] However, established in 2008, the European Patient Smart Open Services project is intended to provide concrete cross-border services that ensure safe, secure, and efficient medical treatment for citizens when traveling across Europe. Two specific areas were identified: a shared patient summary for EU citizens and an Electronic Prescription Service (including e-Dispensing).\[[@ref46]\]

[Table 2](#T2){ref-type="table"} compares the electronic prescription system architecture in the selected countries from ten important dimensions. Based on the results, the electronic prescription system in four European studied countries had centralized architecture and national database. However, the architecture of the US applied was diffused and decentralized. Furthermore, the patient, prescriber, and dispenser were main human actors, as well as the prescribing and dispensing providers were main system actors of the Electronic Prescription central prescription server provider was a system actor of the Electronic Prescription Service in Denmark, Finland, Sweden, and England.

Based on comparing the responsibility of the electronic prescription system in the selected countries, the system of the United States does not have a unit coordinator and leader to create and maintain a national electronic prescription database.\[[@ref47][@ref48][@ref49]\] Financial investment in the technology needed for electronic prescription is done in England in partnership with the private sector (such as system users, pharmacies, hospitals, and physician).\[[@ref22][@ref23][@ref25][@ref45]\] Furthermore, governmental or communal resources were used to set up electronic prescriptions\' systems in Denmark, Finland, Sweden, and England.\[[@ref23]\]

[Table 3](#T3){ref-type="table"} compares the identifiers of the electronic prescription system in the selected countries. The United States, Sweden, and Denmark did not have PUID at the time of creating the electronic prescription. In addition, the only electronic prescription system of the United States lacks a national patient ID.

[Table 4](#T4){ref-type="table"} compares the processes of the electronic prescription system in the selected countries. Only the United States has a process of sending requests of information about patient\'s history and formulary from prescriber systems to the pharmacies and the payers.
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Comparing features of the electronic prescription system in the selected countries (the United States, England, Sweden, Finland, and Denmark) indicates that this system is used routinely or as a pilot at the state, local, or area levels and covers the whole process of prescription or major part of it. Electronic prescription system is used only in Denmark and Sweden routinely at the national level and covers the entire prescription process. Furthermore, the studied countries use different classification, vocabulary, terminology, and data interchange standards in their electronic prescription system. Results of the other studies indicate that each national system selects different approaches toward electronic prescription (regarding the field and starting point, the process of implementation, and technical solutions) and its development. It could be due to differences in their health-care and insurance systems. Differences in approaches to implement this system had an impact on the adoption of the electronic prescription in different countries.\[[@ref50][@ref51][@ref52][@ref53][@ref54][@ref55][@ref56][@ref57][@ref58][@ref59]\] Thus, the countries were at different levels and stages of implementation of the electronic prescription.\[[@ref37][@ref38][@ref39][@ref40][@ref41][@ref42][@ref43][@ref44][@ref45][@ref47][@ref48][@ref49][@ref50][@ref51][@ref52]\] In addition, electronic prescription systems and models in different countries and also even within a country were not similar.\[[@ref45][@ref49][@ref50][@ref51][@ref53]\]

A variety of electronic prescription standards in the countries with this system has been mentioned in various sources.\[[@ref37][@ref52][@ref53][@ref54][@ref55]\] It could be due to different standard trustee organizations in each of the studied countries. Using uniform standards and vocabularies and centralized knowledge bases can prevent from repetitive tasks of the care providers and suppliers.\[[@ref56]\]

Electronic prescription in all the studied countries except England had started from primary health-care centers. In addition, according to an international study that was done in six countries (Australia, New Zealand, England, Northern Ireland, Scotland, and Denmark) titled "EPrescribing and Electronic Transfer of Prescriptions: An International Review," all of them similarly emphasized on electronic prescription and dispensation in outpatient centers and public pharmacies. The similarity of the work processes of pharmacists and general physicians with their other peers have caused to their further support for the computerization of this process. In contrast, pharmaceutical management processes of the hospital is often more complex, so its standardization and computerization is more complex.\[[@ref38]\]

Patient\'s satisfaction for stakeholders\' access to the required information and legality of the prescriber\'s electronic signature were necessary in the legal infrastructure of the electronic prescription system of the studied countries. Electronic prescription law was approved in the United States, England, and Finland. However, the study of Stroetmann *et al*. with the aim of determining the legal challenges on the road toward interoperable ehealth solutions in Europe showed that some of these countries did not use ePescription in primary care due to national legislation forbidding or not addressing the electronic transmission of prescriptions and the use of electronic signatures.\[[@ref45]\] Therefore, further efforts are necessary in these countries to adopt the electronic prescription laws, the electronic transmission of the prescriptions, issuing electronic prescription for controlled medicines, and accepting electronic prescriptions from other countries. Stroetmann *et al*.\'s research also determined legal requirements of the countries about electronic prescription that include authentication, electronic signature of the patient\'s satisfaction, and access to the paper prescription.\[[@ref45]\]

Comparing the architecture of the electronic prescription system in the selected countries showed that the architecture type and components of this system are more similar to each other in four European countries (England, Sweden, Finland, and Denmark), because these countries have a centralized architecture and a national electronic prescription database.\[[@ref25][@ref36][@ref40][@ref42][@ref43][@ref48][@ref51][@ref52][@ref57][@ref58][@ref59][@ref60][@ref61]\] However, the United States used diffused and decentralized architecture and had only a national electronic prescription network (Surescripts).\[[@ref40][@ref49][@ref62]\] Dedicated national health networks such as Sjunet in Sweden\[[@ref63]\] and SDN in Denmark\[[@ref41][@ref42]\] play an increased role in successful implementation of the electronic prescription system because it provides communication between different system stakeholders and transmission of electronic prescriptions.

The United States, England, and Sweden had centers for leading of the electronic health that were responsible for coordinating activities related to health information technology at the national level. In the studied countries, financial investment for the electronic prescription system was mainly done by government and public resources, but in England, part of the cost was financed by the private sector and also in Denmark and Sweden the cost of system development was paid by the actors (service providers and pharmacies). Mäkinen *et al*. in their article similarly expressed that the government, society, or nonuser resources were responsible for financing the electronic prescription infrastructure in the EU countries.\[[@ref23]\] They stated that financing the costs of prescription is an obstacle to use this system at the national level and resulting in slow adoption of the electronic prescription in the future.\[[@ref63]\] Hence, the actors should participate directly in financing the electronic prescription. In addition to financial support of the government or similar organizations, according to Protti *et al*., support also plays important roles in the adoption of electronic prescription in Denmark, England, and Scotland.\[[@ref64]\]

In the electronic prescription system of all the selected countries, a unique identifier was used for physicians and medicines. As well as, patients in the studied European countries (England, Finland, Sweden, and Denmark) had a multipurpose and health unique national ID. The social security number was used as the unique patient\'s identifier in the United States, and based on many resources, the unique identifier of the patient, medication, physician, prescriptions, and pharmacies is necessary to implement the electronic prescription system.\[[@ref40][@ref65][@ref66]\]

Comparing the process of the electronic prescription system showed that some important capabilities exist in the system of the selected countries, including electronic prescription, decision support, selecting the pharmacy by the patient, ETPs both directly or by virtual interface to a pharmacy, retrieving the electronic prescription in the pharmacies, electronic dispensing, and electronically refilling prescriptions. Previous studies about analysis of the work flow and electronic prescription process also mentioned to these activities.
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Based on the results of this study, it is suggested to create a central national prescription database to store the electronic medication prescriptions and pharmacy dispensing documentation. The past experiences from the failures to implement this system indicate that it should be part of the national health-care infrastructure to facilitate safe and secure electronic transmission of prescription between the prescribers and dispensers. The government should also provide legal and financial incentives (preparing hardware and software, offering free technical support and making allowance for implementation) for better acceptance of this system among relevant stakeholders. It is also recommended that message transmission standards and interoperability framework are expanded to support the ETP data between the stakeholders\' organizations. In addition, uniform standards and terminology should be applied in this system to provide an appropriate background for achieving higher levels of electronic prescription system in the future.
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